Cannabis Compounds Show Promise In Fighting Ovarian Cancer
Ovarian cancer continues to be one of the deadliest gynecological diseases worldwide, often diagnosed late and challenging to treat effectively. Recent laboratory research conducted by scientists at Khon Kaen University has revealed promising evidence that compounds derived from cannabis—specifically cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC)—can significantly slow the growth and spread of ovarian cancer cells without harming healthy ones.
Cannabis compounds have attracted rising interest in medical research for their potential therapeutic effects. In this study published in Frontiers in Pharmacology in October 2025, researchers focused on the anti-cancer properties of CBD and THC, substances known, respectively, for their non-psychoactive and psychoactive characteristics. Prior studies suggested these compounds might inhibit cancer cell proliferation and reduce tumour viability.
### Exploring cannabis effects on ovarian cancer cells
The research team tested two ovarian cancer cell lines: one sensitive to platinum-based chemotherapy and the other resistant to such treatment. Cells were exposed to CBD alone, THC alone, and a 1:1 combination of the two, with the survival and multiplication rates closely monitored alongside a control group of healthy cells. Notably, both compounds individually limited the formation of new cancer cell colonies, but it was the combination that produced the most potent inhibitory effect.
Moreover, treatment with the combined CBD-THC compounds markedly reduced the ability of cancer cells to migrate, a critical factor in preventing metastasis or cancer spread. This is especially significant since metastasis is a primary cause of ovarian cancer mortality. Importantly, healthy cells showed minimal adverse responses to the compounds, indicating the potential for treatments with fewer side effects compared to existing chemotherapies.
### Understanding the cellular mechanisms
The inhibition of the PI3K/AKT/mTOR signalling pathway—known to be overactivated in many ovarian cancers—was identified as the likely mechanism by which these cannabis derivatives exert their effects. By restoring normal pathway regulation, CBD and THC seem to counter tumour growth and enhance cancer cell death.
### Implications for Zimbabwean cancer care
Zimbabwe faces challenges in cancer diagnosis and treatment, with ovarian cancer contributing significantly to women’s health burdens. The potential of cannabis-derived therapies aligns closely with Zimbabwe’s National Development Strategy 1 (NDS1) goals of improving healthcare accessibility and fostering innovative medical solutions. Pioneering research and clinical trials involving local institutions such as the University of Zimbabwe’s medical faculty could facilitate introducing cannabinoid-based treatments, especially those that prove less toxic and more affordable.
Furthermore, empowering women and youth within rural farming communities to participate in cultivating medicinal cannabis could create livelihoods and expand domestic supply chains, integrating agricultural innovation with healthcare advancement.
### Path to future therapies
While these laboratory findings are an encouraging first step, Dr Siyao Tong, lead author, emphasises that all experiments to date have been conducted in vitro (in the laboratory on isolated cells). “We need extensive in vivo studies and clinical trials to establish safety, dosage, and efficacy in humans,” she explained. Regulatory and legal frameworks governing cannabis-based medicines also present challenges that must be navigated carefully.
Despite these hurdles, the study lays a critical foundation for developing new ovarian cancer treatments that could eventually complement or replace current options. The prospect of combining CBD and THC to create more effective, less toxic therapies offers renewed hope to patients confronting this aggressive disease.
### The wider agricultural opportunity
Zimbabwe’s agriculture sector could play a pivotal role in supporting the medicinal cannabis industry. With conducive climate conditions and expanding expertise, cultivating cannabis specifically for medicinal compounds presents an opportunity to diversify crops and increase export potential, aligned with NDS1’s objectives to boost economic growth and innovation.
Ensuring policies support sustainable and responsible cannabis production will be key for Zimbabwe to benefit from both health and economic fronts. This innovative approach aligns with global trends and showcases how science, health, and agriculture can synergise for national development.
### Conclusion
The promising anti-cancer effects of cannabis compounds CBD and THC on ovarian cancer cells signify a hopeful breakthrough, potentially altering future treatment landscapes worldwide, including Zimbabwe. With continued research, clinical validation, and supportive policies, cannabis-based therapies may herald safer, effective options that improve survival rates and quality of life for women battling ovarian cancer. Meanwhile, Zimbabwe’s agricultural and healthcare sectors have vital roles to play in realising these benefits, empowering communities, and advancing national development priorities.
FFA Explainer Box: What is Ovarian Cancer?
Ovarian cancer originates in the ovaries, the female reproductive organs that produce eggs and hormones. It is often asymptomatic in early stages, leading to late diagnosis and higher mortality. Current treatments include surgery, chemotherapy, and targeted therapies but can cause significant side effects and may not be effective for resistant cancer types.
FFA Explainer Box: What are CBD and THC?
CBD (cannabidiol) and THC (delta-9-tetrahydrocannabinol) are natural compounds found in cannabis plants. THC is psychoactive, causing the “high” sensation, while CBD is non-psychoactive. Both have shown medicinal properties, such as pain relief and anti-inflammatory effects, and are under study for cancer treatment potentials.
About The Author
